Research Papers:

A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells

Wenhui Zhang _, Huanhuan Yang, Yanna Zhang, Yanan Lu, Tianlin Zhou, Meng Li, Yanjun Wen, Xiaojuan Lin, Rong Xiang and Xiancheng Chen

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:40762-40774. https://doi.org/10.18632/oncotarget.5691

Metrics: PDF 2678 views  |   HTML 3683 views  |   ?  


Wenhui Zhang1,*, Huanhuan Yang1,*, Yanna Zhang1,*, Yanan Lu1,*, Tianlin Zhou1, Meng Li1, Yanjun Wen2, Xiaojuan Lin2, Rong Xiang3, Xiancheng Chen1

1National Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China

2Department of Gynecology & Obstetrics, West China Hospital/Second Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China

3Department of Immunology, Nankai University School of Medicine, Tianjin, People's Republic of China

*These authors have contributed equally to this work

Correspondence to:

Xiancheng Chen, e-mail: [email protected] or [email protected]

Keywords: stem cells, 3D-spheroid, molecule microenvironment, immune renewal

Received: April 04, 2015     Accepted: September 14, 2015     Published: October 19, 2015


CSCs are able to survive routine anticancer procedures and peripheral-immune attack. Here we develop and detail a framework of CSC elimination governed by 3D-biologics. Pluripotent cells-engineered 3D-biologics (PMSB) and control non-3D-biologics were prepared from placenta-based somatic stem cells (PSCs) and inoculated respectively into senile hosts bearing progressive mammary, lung, colon carcinomas and melanoma. We demonstrate that PMSB evokes in vivo central-immune microenvironment with subsequent re-expression of thymosin-α1 ~ β4 in thymic cortex-medulla borderline for rapid MHC-unrestricted renewal of γδT-dominated immunocompetence. The post-renewal γδT-subsets could accurately bind and drive CSCs into apoptosis. Finally, with central/peripheral integral microenvironment renewal and TERT/Wnt/β-catenin pathway blockade, the CSC-subsets are fully depleted, leading to substantial cure of diverse tumors by PMSB inoculation (P < 0.01), yet not by non-3D-biologics. Thus, our study may contribute to open up a new avenue for tumor remission via pluripotent cells-engineered 3D-biologics addressing quick renewal of central-thymus and peripheral immune-microenvironment.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5691